Precision off-the-shelf natural killer cell therapies for oncology with logic-gated gene circuits

Summary: Acute myeloid leukemia (AML) is an aggressive disease with a poor prognosis (5-year survival rate of 30.5% in the United States). Designing cell therapies to target AML is challenging because no single tumor-associated antigen (TAA) is highly expressed on all cancer subpopulations. Furtherm...

Cijeli opis

Bibliografski detalji

Glavni autori:	Nicholas W. Frankel, Han Deng, Gozde Yucel, Marcus Gainer, Nelia Leemans, Alice Lam, Yongshuai Li, Michelle Hung, Derrick Lee, Chen-Ting Lee, Andrew Banicki, Mengxi Tian, Niran Almudhfar, Lawrence Naitmazi, Assen Roguev, Seunghee Lee, Wilson Wong, Russell Gordley, Timothy K. Lu, Brian S. Garrison
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2024-05-01
Serija:	Cell Reports
Teme:	CP: Immunology CP: Cancer
Online pristup:	http://www.sciencedirect.com/science/article/pii/S221112472400473X
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!